Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page
- Check5 days agoChange DetectedPublications section now lists the NEJM paper on sotatercept for high-risk PAH. The results posting date is shown as 2025-08-22.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNo significant changes detected.SummaryDifference0.2%

- Check34 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check41 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%

- Check56 days agoChange DetectedVersion bumped to v3.0.2 (from v3.0.1); the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.